| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1203b9130a60c06c4f085efe9ae14a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eff969cde9b063a2ff4e31ca8c67c877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ab959fb23c948ea41e062c240c1b727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db5e681649675eacdd7842b15cf355a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00 |
| filingDate |
2005-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f7bbba09fc38f590b2ff34bd7f70872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab1aace7759133d8f3beca5fefaafd61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0fd6d7832669e0cc3723f112140797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_516b85cc33f01b6fca5827bdf6f51ccf |
| publicationDate |
2005-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005106013-A2 |
| titleOfInvention |
Use of mdck cell line to predict corneal penetration of drugs |
| abstract |
A new method of evaluating the ability of drug molecules to penetrate the cornea is described. The permeation rate of the drug molecules in MDCK cells is utilized to predict the ability of the molecules to penetrate the cornea. The method is useful for in vitro screening of potential new ophthalmic drugs, as well as in the design of new drug molecules for topical ocular administration. |
| priorityDate |
2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |